Fragen an den Experten

tada

Seizure Medication


Frage

My 19-year-old daughter with CdLS has been on Phenobarbitol since the age of one. Recently, a dosage was not given and since then she has had the occasional seizure. She is also having severe mood swings. Her neurologist wants to now put her on Lamictal but I am concerned about the side effects.

Antwort unserer Experten

I discussed Lamictal with a pediatric neurologist colleague. He said that it seems to be a very good drug in controlling seizures. The biggest risk he reported (1%) was the development of a rash, which can be severe enough to require hospitalization. The risk for the rash is higher if the child is less than two years of age. There do not appear to be other toxic side effects, and he felt that there were no painful side effects, nor any affect on cognition. The major contraindication to taking Lamictal was if the seizures were of a certain type (myoclonus), that you did not report in your daughter. I think you have to weigh what you feel are the risks against your daughter having the seizures

TK 7-13-10

SEE ALSO: Seizure Auras, 
Seizure Onset Age, 
Seizure Effects
, Seizures

Antwort ist geprüft und gültig für
us
Weitere Seiten mit demselben Thema finden Autonomic nervous system

Empfehlung(en)

Autonomic nervous system

R47
Seizures in individuals with CdLS should be treated using the general management schemes.
R48
An MRI of the brain should be considered only if the individual with CdLS shows neurological signs other than microcephaly (smaller than normal head).

Rechtlicher Haftungsausschluss

Bitte beachten Sie, dass der Fragen an den Experten Service aus freiwilligen Fachleuten verschiedener Fachgebiete besteht. Die Antworten sind nicht als medizinische, verhaltensbezogene oder pädagogische Beratung zu verstehen. Fragen an den Experten ist kein Ersatz für die Betreuung durch den persönlichen Arzt, Psychologen, Erziehungsberater oder Sozialarbeiter Ihres Kindes.

Haben Sie eine Frage, die Sie gerne stellen möchten?

Eine Frage stellen